J Mov Disord.  2019 May;12(2):67-83. 10.14802/jmd.18067.

Altered Gut Microbiome and Intestinal Pathology in Parkinson's Disease

Affiliations
  • 1Department of Neurology, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan.
  • 2Department of Neurology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan. chlin@ntu.edu.tw

Abstract

Parkinson's disease (PD) is a common neurodegenerative disorder arising from an interplay between genetic and environmental risk factors. Studies have suggested that the pathological hallmarks of intraneuronal α-synuclein aggregations may start from the olfactory bulb and the enteric nervous system of the gut and later propagate to the brain via the olfactory tract and the vagus nerve. This hypothesis correlates well with clinical symptoms, such as constipation, that may develop up to 20 years before the onset of PD motor symptoms. Recent interest in the gut-brain axis has led to vigorous research into the gastrointestinal pathology and gut microbiota changes in patients with PD. In this review, we provide current clinical and pathological evidence of gut involvement in PD by summarizing the changes in gut microbiota composition and gut inflammation associated with its pathogenesis.

Keyword

Microbiome; Gut inflammation; Gut–brain axis; Parkinson's disease

MeSH Terms

Brain
Constipation
Enteric Nervous System
Gastrointestinal Microbiome*
Humans
Inflammation
Microbiota
Neurodegenerative Diseases
Olfactory Bulb
Parkinson Disease*
Pathology*
Risk Factors
Vagus Nerve
Full Text Links
  • JMD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr